Search research articles
Contact Us
Filters
Showing results (391-400 of 1,142) with videos related to
Page
of 115
Sort By:
EMBO Molecular Medicine
|
November 13, 2012
MicroRNA-146a-mediated downregulation of IRAK1 protects mouse and human small intestine against ischemia/reperfusion injury
Cécilia Chassin, Cordelia Hempel, Silvia Stockinger, et al.
Frontiers in Physiology
|
January 1, 2014
Hepatitis E in liver biopsies from patients with acute hepatitis of clinically unexplained origin
Uta Drebber, Margarete Odenthal, Stephan W Aberle, et al.
Journal of Viral Hepatitis
|
October 19, 2024
Limited Value of HBV-RNA for Relapse Prediction After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative Hepatitis B Patients
Valerie Ohlendorf, Maximilian Wübbolding, Christoph Höner Zu Siederdissen, et al.
Zeitschrift Fur Gastroenterologie
|
May 13, 2025
Impact of distinct antiviral treatment regimens on the long-term outcome after HCV cure - Data from the German Hepatitis C-Registry (DHC-R)
Valerie Ohlendorf, Yvonne Serfert, Peter Buggisch, et al.
Open Biology
|
December 20, 2013
Cholinergic efferent synaptic transmission regulates the maturation of auditory hair cell ribbon synapses
Stuart L Johnson, Carolina Wedemeyer, Douglas E Vetter, et al.
European Journal of Gastroenterology & Hepatology
|
June 25, 2009
Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany
Charalabos-Markos Dintsios, Alexander Haverkamp, Johannes Wiegand, et al.
Journal of Virological Methods
|
December 23, 2014
Importance of very early HCV RNA kinetics for prediction of treatment outcome of highly effective all oral direct acting antiviral combination therapy
Christoph Sarrazin, Heiner Wedemeyer, Gavin Cloherty, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 24, 2022
Low anti-HBc levels are associated with lower risk of virological relapse after nucleos(t)ide analogue cessation in HBe antigen-negative patients
Valerie Ohlendorf, Maximilian Wübbolding, Paul Gineste, et al.
Klinische Padiatrie
|
July 24, 2020
[School Absenteeism - Requirements for a Successful Therapeutic Approach]
Lorenz Hilwerling, Marie Linnenbank, Heike Flockert, et al.
Scientific Reports
|
November 7, 2024
Limited stability of Hepatitis B virus RNA in plasma and serum
Valerie Ohlendorf, Birgit Bremer, Lisa Sandmann, et al.
Page
of 115
Search research articles
Search
Showing results (391-400 of 1,142) with videos related to
Sort By:
Page
of 115
EMBO Molecular Medicine
|
November 13, 2012
MicroRNA-146a-mediated downregulation of IRAK1 protects mouse and human small intestine against ischemia/reperfusion injury
Cécilia Chassin, Cordelia Hempel, Silvia Stockinger, et al.
Frontiers in Physiology
|
January 1, 2014
Hepatitis E in liver biopsies from patients with acute hepatitis of clinically unexplained origin
Uta Drebber, Margarete Odenthal, Stephan W Aberle, et al.
Journal of Viral Hepatitis
|
October 19, 2024
Limited Value of HBV-RNA for Relapse Prediction After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative Hepatitis B Patients
Valerie Ohlendorf, Maximilian Wübbolding, Christoph Höner Zu Siederdissen, et al.
Zeitschrift Fur Gastroenterologie
|
May 13, 2025
Impact of distinct antiviral treatment regimens on the long-term outcome after HCV cure - Data from the German Hepatitis C-Registry (DHC-R)
Valerie Ohlendorf, Yvonne Serfert, Peter Buggisch, et al.
Open Biology
|
December 20, 2013
Cholinergic efferent synaptic transmission regulates the maturation of auditory hair cell ribbon synapses
Stuart L Johnson, Carolina Wedemeyer, Douglas E Vetter, et al.
European Journal of Gastroenterology & Hepatology
|
June 25, 2009
Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany
Charalabos-Markos Dintsios, Alexander Haverkamp, Johannes Wiegand, et al.
Journal of Virological Methods
|
December 23, 2014
Importance of very early HCV RNA kinetics for prediction of treatment outcome of highly effective all oral direct acting antiviral combination therapy
Christoph Sarrazin, Heiner Wedemeyer, Gavin Cloherty, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 24, 2022
Low anti-HBc levels are associated with lower risk of virological relapse after nucleos(t)ide analogue cessation in HBe antigen-negative patients
Valerie Ohlendorf, Maximilian Wübbolding, Paul Gineste, et al.
Klinische Padiatrie
|
July 24, 2020
[School Absenteeism - Requirements for a Successful Therapeutic Approach]
Lorenz Hilwerling, Marie Linnenbank, Heike Flockert, et al.
Scientific Reports
|
November 7, 2024
Limited stability of Hepatitis B virus RNA in plasma and serum
Valerie Ohlendorf, Birgit Bremer, Lisa Sandmann, et al.
Page
of 115